General Range

FORCLOFEN-SP

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORCLOFEN-SP Tablets by Fortune Labs contain Diclofenac, Paracetamol and Serratiopeptidase, a prescription combination intended for selected painful and inflammatory conditions. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain, swelling and inflammation, while Paracetamol provides additional analgesic and antipyretic effects. Serratiopeptidase is a proteolytic enzyme investigated for its potential role in managing tissue swelling, although clinical evidence remains limited. FORCLOFEN-SP may be prescribed for selected joint pain, muscle discomfort, dental pain, sprains and postoperative symptoms when clinically appropriate. Available in blister strip packaging of 10 × 10 tablets, the medicine requires medical supervision, considering gastrointestinal health, kidney function, liver safety, cardiovascular risks, potential medication interactions and recommended treatment duration.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Diclofenac, Paracetamol & Serratiopeptidase Tablets
Packaging Type: Orange Tablets in Blister Strips with Printed Carton Box
Packaging Size: 10 × 10
Dosage Form: Tablet
Treatment: May provide symptomatic relief from selected inflammation-related joint discomfort.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?